Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

Lisa Salvatore; Giuseppe Aprile; Ermenegildo Arnoldi; Carlo Aschele; Carlo Carnaghi; Maurizio Cosimelli; Evaristo Maiello; Nicola Normanno; Stefania Sciallero; Francesca Valvo; Giordano D Beretta

doi:10.1136/esmoopen-2016-000147

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

Lisa Salvatore, Giuseppe Aprile, Ermenegildo Arnoldi, Carlo Aschele, Carlo Carnaghi, Maurizio Cosimelli, Evaristo Maiello, Nicola Normanno, Stefania Sciallero, Francesca Valvo, Giordano D Beretta

Research output: Contribution to journal › Article

Abstract

In the past 15 years, the outcome for patients with metastatic colorectal cancer has substantially improved owing to the availability of new cytotoxic and biological agents along with many significant advances in molecular selection, the use of personalised therapy and locoregional treatment, a more widespread sharing of specific professional experiences (multidisciplinary teams with oncologists, surgeons, radiotherapists, radiologists, biologists and pathologists), and the adoption of patient-centred healthcare strategies. The Italian Medical Oncology Association (AIOM) has developed evidence-based recommendations to help oncologists and all professionals involved in the management of patients with metastatic colorectal cancer in their daily clinical practice.

Original language	English
Pages (from-to)	e000147
Journal	ESMO Open
Volume	2
Issue number	1
DOIs	https://doi.org/10.1136/esmoopen-2016-000147
Publication status	Published - 2017

Fingerprint

Cite this

Salvatore, L., Aprile, G., Arnoldi, E., Aschele, C., Carnaghi, C., Cosimelli, M., Maiello, E., Normanno, N., Sciallero, S., Valvo, F., & Beretta, G. D. (2017). Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM). ESMO Open, 2(1), e000147. https://doi.org/10.1136/esmoopen-2016-000147

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM). / Salvatore, Lisa; Aprile, Giuseppe; Arnoldi, Ermenegildo; Aschele, Carlo; Carnaghi, Carlo ; Cosimelli, Maurizio ; Maiello, Evaristo ; Normanno, Nicola ; Sciallero, Stefania; Valvo, Francesca; Beretta, Giordano D.

In: ESMO Open, Vol. 2, No. 1, 2017, p. e000147.

Research output: Contribution to journal › Article

Salvatore, Lisa ; Aprile, Giuseppe ; Arnoldi, Ermenegildo ; Aschele, Carlo ; Carnaghi, Carlo ; Cosimelli, Maurizio ; Maiello, Evaristo ; Normanno, Nicola ; Sciallero, Stefania ; Valvo, Francesca ; Beretta, Giordano D. / Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM). In: ESMO Open. 2017 ; Vol. 2, No. 1. pp. e000147.

@article{c221c96355ae417bbd83d1a5c5d8f07e,

title = "Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)",

abstract = "In the past 15 years, the outcome for patients with metastatic colorectal cancer has substantially improved owing to the availability of new cytotoxic and biological agents along with many significant advances in molecular selection, the use of personalised therapy and locoregional treatment, a more widespread sharing of specific professional experiences (multidisciplinary teams with oncologists, surgeons, radiotherapists, radiologists, biologists and pathologists), and the adoption of patient-centred healthcare strategies. The Italian Medical Oncology Association (AIOM) has developed evidence-based recommendations to help oncologists and all professionals involved in the management of patients with metastatic colorectal cancer in their daily clinical practice.",

author = "Lisa Salvatore and Giuseppe Aprile and Ermenegildo Arnoldi and Carlo Aschele and Carlo Carnaghi and Maurizio Cosimelli and Evaristo Maiello and Nicola Normanno and Stefania Sciallero and Francesca Valvo and Beretta, {Giordano D}",

year = "2017",

doi = "10.1136/esmoopen-2016-000147",

language = "English",

volume = "2",

pages = "e000147",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

AU - Salvatore, Lisa

AU - Aprile, Giuseppe

AU - Arnoldi, Ermenegildo

AU - Aschele, Carlo

AU - Carnaghi, Carlo

AU - Cosimelli, Maurizio

AU - Maiello, Evaristo

AU - Normanno, Nicola

AU - Sciallero, Stefania

AU - Valvo, Francesca

AU - Beretta, Giordano D

PY - 2017

Y1 - 2017

N2 - In the past 15 years, the outcome for patients with metastatic colorectal cancer has substantially improved owing to the availability of new cytotoxic and biological agents along with many significant advances in molecular selection, the use of personalised therapy and locoregional treatment, a more widespread sharing of specific professional experiences (multidisciplinary teams with oncologists, surgeons, radiotherapists, radiologists, biologists and pathologists), and the adoption of patient-centred healthcare strategies. The Italian Medical Oncology Association (AIOM) has developed evidence-based recommendations to help oncologists and all professionals involved in the management of patients with metastatic colorectal cancer in their daily clinical practice.

AB - In the past 15 years, the outcome for patients with metastatic colorectal cancer has substantially improved owing to the availability of new cytotoxic and biological agents along with many significant advances in molecular selection, the use of personalised therapy and locoregional treatment, a more widespread sharing of specific professional experiences (multidisciplinary teams with oncologists, surgeons, radiotherapists, radiologists, biologists and pathologists), and the adoption of patient-centred healthcare strategies. The Italian Medical Oncology Association (AIOM) has developed evidence-based recommendations to help oncologists and all professionals involved in the management of patients with metastatic colorectal cancer in their daily clinical practice.

U2 - 10.1136/esmoopen-2016-000147

DO - 10.1136/esmoopen-2016-000147

M3 - Article

VL - 2

SP - e000147

JO - ESMO Open

JF - ESMO Open

SN - 2059-7029

IS - 1

ER -

Access to Document

10.1136/esmoopen-2016-000147

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519792/